Contact HealthDay
Tel: 203.855.1400 or E-mail

News By Specialty

Allergy
Anesthesiology
Cardiology
Cosmetic Surgery
Critical Care
Dermatology
Diabetes & Endocrinology
Emergency Medicine
Family Practice
Gastroenterology
Geriatrics
Hematology & Oncology
HIV & AIDS
Infectious Disease
Internal Medicine
Nephrology
Neurology
Nursing
OBGYN & Women's Health
Ophthalmology
Orthopedics
Otolaryngology
Pain Management
Pathology
Pediatrics
Pharmacy
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Follow us on:

    


e-Healthcare Leadership Awards


Natalizumab Shows Promise for Teens With Multiple Sclerosis
Significant reductions in average annualized relapse rates seen with treatment
This article is older than one year and is no longer available.

Copyright © 2013 HealthDay. All rights reserved.

August 22, 2014

Archive Search

By Keyword:
By Category:
By Topic:

Related Articles

Age Affects Link Between Obesity, Dementia Risk

Infections May Up Pediatric Stroke Risk in Short Term

FDA: New Test Helps Diagnose Type 1 Diabetes

CDC: Teens Engage in Unsafe Skin-Protection Practices

New Therapy May Combat Lethal Virus in Late Stages

FDA Approves Cerdelga for Type 1 Gaucher Disease